©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: Innocann Pharma
Innocan Pharma Reports Q3 2023 Results
HERZLIYA, Israel, and CALGARY, Alberta -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF), a pharmaceutical technology company focusing on developing innovative drug delivery...
Innocan Pharma Announces Closing of Second and Final Tranche of Financing
HERZLIYA, Israel, and CALGARY, Alberta -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has...
Innocan Pharma Announces Private Placement of Units at a 9% Prime Above Share Price
HERZLIYA, Israel, and CALGARY, Alberta -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it...